Establishment Labs Holdings (ESTA) Total Liabilities (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Total Liabilities came in at $336.3 million in Q1 2026, up 14.06% year-on-year from $294.8 million in Q1 2025, and up 0.79% quarter-over-quarter from $333.6 million in Q4 2025.
Establishment Labs Holdings (ESTA) Total Liabilities (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Total Liabilities history runs 10 years deep, the most recent figure standing at $336.3 million for Q1 2026.
- On a quarterly basis, Total Liabilities rose 14.06% year-over-year to $336.3 million in Q1 2026; TTM through Mar 2026 was $336.3 million, a 14.06% increase from a year earlier, with the FY2025 full-year figure at $333.6 million, up 13.58% from the prior year.
- Total Liabilities advanced to $336.3 million in Q1 2026 per ESTA's latest filing, from $333.6 million in the prior quarter.
- Across five years, Total Liabilities topped out at $336.3 million in Q1 2026 and bottomed at $93.7 million in Q1 2022.
- The 5-year median for Total Liabilities is $244.9 million (2024), against an average of $250.1 million.
- Across the five-year window, Total Liabilities surged 146.93% in 2022 and climbed 4.14% in 2024, its largest moves.
- Year by year, Total Liabilities stood at $219.2 million in 2022, then gained by 14.14% to $250.2 million in 2023, then gained by 17.38% to $293.7 million in 2024, then rose by 13.58% to $333.6 million in 2025, then increased by 0.79% to $336.3 million in 2026.
- Per Business Quant, the three latest ESTA Total Liabilities figures stand at $336.3 million (Q1 2026), $333.6 million (Q4 2025), and $322.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 23.31 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.99 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.68 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 18.55 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.23 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.17 Bn |
| 10 | Establishment Labs Holdings | 2.73 Bn | 2.66 Bn | 42.34 Mn | 336.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 336.25 Mn |
| Dec 31, 2025 | 333.62 Mn |
| Sep 30, 2025 | 322.53 Mn |
| Jun 30, 2025 | 306.91 Mn |
| Mar 31, 2025 | 294.81 Mn |
| Dec 31, 2024 | 293.74 Mn |
| Sep 30, 2024 | 249.98 Mn |
| Jun 30, 2024 | 240.07 Mn |
| Mar 31, 2024 | 244.93 Mn |
| Dec 31, 2023 | 250.25 Mn |
| Sep 30, 2023 | 240.05 Mn |
| Jun 30, 2023 | 230.43 Mn |
| Mar 31, 2023 | 225.36 Mn |
| Dec 31, 2022 | 219.25 Mn |
| Sep 30, 2022 | 186.13 Mn |
| Jun 30, 2022 | 184.02 Mn |
| Mar 31, 2022 | 93.72 Mn |
| Dec 31, 2021 | 88.79 Mn |
| Sep 30, 2021 | 86.80 Mn |
| Jun 30, 2021 | 83.29 Mn |